Pages that link to "Q28250152"
Jump to navigation
Jump to search
The following pages link to Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors (Q28250152):
Displaying 20 items.
- A Case of Painless Legs and Moving Toes Syndrome in Parkinson's Disease Responsive to Dopaminergic Therapy (Q27312273) (← links)
- Targeting the dopamine D3 receptor: an overview of drug design strategies (Q34524556) (← links)
- Transdermal Patch of Rotigotine Attenuates Freezing of Gait in Patients with Parkinson's Disease: An Open-Label Comparative Study of Three Non-Ergot Dopamine Receptor Agonists (Q37383141) (← links)
- A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease (Q38662579) (← links)
- Efficacy and safety of rotigotine in elderly patients with Parkinson's disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials (Q47430695) (← links)
- Different effects of rotigotine and ropinirole on cholinergic transmission in the mouse medial prefrontal cortex (Q47744210) (← links)
- Targeting hypersensitive corticostriatal terminals in restless legs syndrome (Q47952336) (← links)
- Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson's disease (Q49438954) (← links)
- Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication (Q50243244) (← links)
- In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor (Q51740015) (← links)
- The efficacy and tolerability of rotigotine on patients with periodic limb movement in sleep: A systematic review and meta-analysis. (Q55302709) (← links)
- Restless Legs Syndrome and Other Movement Disorders of Sleep-Treatment Update (Q58563261) (← links)
- Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease (Q58700802) (← links)
- In vitro and in silico analysis of the effects of D receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations (Q58703159) (← links)
- Binding kinetics of cariprazine and aripiprazole at the dopamine D receptor (Q58730805) (← links)
- Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease (Q64779657) (← links)
- Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report (Q88858403) (← links)
- Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease (Q92812717) (← links)
- Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome (Q98290473) (← links)
- A clinical improvement of a idiopathic cervical dystonia in a patient treated with transdermal Rotigotine: a case-report (Q99402821) (← links)